Want to join the conversation?
$COST said that IT monetization efforts negatively impacted SG&A expenses in 3Q16 on an incremental YoverY basis by about $16MM, which is about 5 BP or $0.02 a share to SG&A. The company said that it recorded a pretax LIFO credit of $13MM in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?